改进型肺结核血检产品发布
|
By LabMedica International staff writers Posted on 06 Dec 2017 |
|
图片：QuantiFERON-TB Gold Plus (QFT-Plus)是第四代领先的肺结核血检产品（图片蒙凯杰公司惠赐）。
肺结核(TB)是一种细菌感染，主要通过活跃肺结核患者的咳嗽传播。据估计，2015年全世界有1040万活跃肺结核的新病例，肺结核导致180万例死亡。
有潜伏肺结核感染(LTBI)时，人感染了细菌却没产生症状，除非后来发展成活跃疾病。全球范围内，估计每三人中就有一人有潜伏肺结核感染，其中约5%-10%的人如果不接受治疗将在某个时候发展成活跃肺结核。
筛查高风险人群和治疗LTBI在美国和许多欧洲国家以及世界上其它发达国家和新兴市场控制肺结核的行动中发挥着重要作用。第四代肺结核血液检验试剂盒已经发布，并于2017年10月9日在美国上市。新颖的CD4/CD8设计能够最全面地评估病人对肺结核感染的免疫应答。
德国希尔登凯杰公司的QuantiFERON-TB Gold Plus (QFT-Plus)采用创新性抗原测量CD4+和CD8+ T细胞介导的对肺结核感染的免疫应答，推动了肺结核检验技术的进步，能更全面地评估肺结核感染。研究显示CD8+ T细胞对于结核分枝杆菌的免疫起着重要作用。已发表的证据凸显了CD8+ T细胞将来区分活跃肺结核与潜伏肺结核、区分最近病毒与以前感染、检测共感染人类免疫缺陷病毒(HIV)的人群以及幼儿体内的肺结核以及评估人对肺结核治疗的反应的潜力。其它检验没有针对CD4和CD8 T细胞应答做优化。
凯杰公司肺结核医疗与科研事业部高级主管Masae Kawamura大夫说：“QFT-Plus的CD4+/CD8+ T细胞专利技术有望提供有关高风险患者的重要信息，如哪些人接触过活跃肺结核患者或HIV阳性者，同时维持高特异性。在美国，检验准确度从未如此重要，因为该国重拳出击，利用政策推行定向检验和预防性治疗，以遏止肺结核。目前估计美国93%的肺结核病来自1300万潜伏肺结核感染者。”
Related Links:
凯杰公司
有潜伏肺结核感染(LTBI)时，人感染了细菌却没产生症状，除非后来发展成活跃疾病。全球范围内，估计每三人中就有一人有潜伏肺结核感染，其中约5%-10%的人如果不接受治疗将在某个时候发展成活跃肺结核。
筛查高风险人群和治疗LTBI在美国和许多欧洲国家以及世界上其它发达国家和新兴市场控制肺结核的行动中发挥着重要作用。第四代肺结核血液检验试剂盒已经发布，并于2017年10月9日在美国上市。新颖的CD4/CD8设计能够最全面地评估病人对肺结核感染的免疫应答。
德国希尔登凯杰公司的QuantiFERON-TB Gold Plus (QFT-Plus)采用创新性抗原测量CD4+和CD8+ T细胞介导的对肺结核感染的免疫应答，推动了肺结核检验技术的进步，能更全面地评估肺结核感染。研究显示CD8+ T细胞对于结核分枝杆菌的免疫起着重要作用。已发表的证据凸显了CD8+ T细胞将来区分活跃肺结核与潜伏肺结核、区分最近病毒与以前感染、检测共感染人类免疫缺陷病毒(HIV)的人群以及幼儿体内的肺结核以及评估人对肺结核治疗的反应的潜力。其它检验没有针对CD4和CD8 T细胞应答做优化。
凯杰公司肺结核医疗与科研事业部高级主管Masae Kawamura大夫说：“QFT-Plus的CD4+/CD8+ T细胞专利技术有望提供有关高风险患者的重要信息，如哪些人接触过活跃肺结核患者或HIV阳性者，同时维持高特异性。在美国，检验准确度从未如此重要，因为该国重拳出击，利用政策推行定向检验和预防性治疗，以遏止肺结核。目前估计美国93%的肺结核病来自1300万潜伏肺结核感染者。”
Related Links:
凯杰公司
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Gold Member
Hematology Analyzer
Medonic M32B
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Latest 免疫学 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more